Does Radioiodine Therapy in Patients with Differentiated Thyroid Cancer Increase the Frequency of Another Malignant Neoplasm?

Table 2

Clinical and epidemiological characteristics of 15 patients with differentiated thyroid carcinoma and another malignancy.

Clinical and epidemiological characteristic	Another malignancy		P
	Postiodine; 𝑁=7 (46.66%)	Preiodine; 𝑁=8 (53.33%)
Males N (%)	4 (57.14)	3 (37.5)	0.6193
Age at thyroidectomy (years)*	61 ± 17	51 ± 13.7	0.2295
Follow-up period (months)**	75 (48; 336)	56.5 (20; 60)	0.1505
Age at diagnosis of a second neoplasia* (years)	69.4 ± 11.4	46.1 ± 20.2	0.0187
Classic nonpapilliferous histological type N (%)	3 (42.85)	2 (25)	0.6084

*mean ± standard deviation; **median (minimum value; maximum value).